Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2018
At a glance
- Drugs Topiramate (Primary)
- Indications Obsessive-compulsive disorders
- Focus Adverse reactions; Therapeutic Use
- 25 May 2018 Status changed from recruiting to completed.
- 26 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History